top of page
Chemistry Class

INNOVATE & CURE

Dedicated to developing cutting-edge therapeutic antibodies, REMUUN is committed to transforming healthcare and saving lives.

Explore

Meet The Team

Chahwan passport photo 2023.jpeg

Prof Dr Richard Chahwan

Founder & iCEO

  • Grey LinkedIn Icon

With a latest stint as head of the Cancer Immunobiology Lab - University of Zurich and with degrees from the University of Toronto  & University of Cambridge, I bring innovative ideas, interdisciplinary experience, and rigor to REMUUN.

REMUUN VK3 team photo 2025_edited.jpg

Romina Fetti, MBA

CFO / CBO

As an economist and business specialist with over 30+ years of experience I support REMUUN in all aspects finance and business development.

REMUUN VK3 team photo 2025_edited.png

Paulina Wyrzykowska

VP Research

As a scientist with 20+ years of research experience I support REMUUN in all aspects involving biochemical, molecular, and cellular needs.

OUR INNOVATIVE BIOTECH PLATFORM
MEGA

At REMUUN, we strive to revolutionize the biotech industry with our advanced MEGA therapeutic antibody development platform. Founded by Prof. Dr. Richard Chahwan, we are dedicated to creating therapeutic monoclonal antibodies 50x faster and more effectively.

This will drive the future of medicine, enhance patient care, and improve global health outcomes

bottom of page